S136-operationalizing an enhanced recovery protocol after bariatric surgery: single institutional pilot experience forging data-driven standard work.

Background: Enhanced recovery protocols (ERPs) after metabolic and bariatric surgery (MBS) may help decrease length of stay (LOS) and postoperative nausea/vomiting but implementation is often fraught with challenges. The primary aim of this pilot study was to standardize a MBS ERP with a real-time data support dashboard and checklist and assess impact on global and individual element compliance. The secondary aim was to evaluate 30 day outcomes including LOS, hospital readmissions, and re-operations.

PPE training and the effectiveness of universal masking in preventing exposures: The importance of the relationship between anesthesia and infection prevention.

Early in the pandemic, infection prevention (IP), in collaboration with our local anesthesia leadership, took the approach of ensuring all members of the Anesthesia Department understood the importance of universal masking, were individually trained on the use of the Controlled Air Purifier Respirator, as well the appropriate method for donning/doffing N95 respirators. Multiple providers in the department tested positive for COVID, resulting in the IP Department to conduct the routine contact tracing investigation. During the investigation, it was determined that all persons who met the CDC (Centers for Disease Control & Prevention) contact exposure guidelines would undergo COVID testing, which consequently was 109 team members due to the exposure risk identified in the break room space.

Liposomal bupivacaine and novel local anesthetic formulations.

Novel preparations allowing for the extended duration of action of local anesthetics have many clinically relevant benefits. With regard to this, the development of liposomal bupivacaine has the potential to significantly impact patient care by improving perioperative pain control. The unique liposomal bilayer that encapsulates bupivacaine allows for a sustained release of local anesthetic for up to 72 h after a single use and can significantly decrease postoperative opioid consumption.